...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Isolation of HL-60 cancer cells from the human serum sample using MnO2-PEI/Ni/Au/aptamer as a novel nanomotor and electrochemical determination of thereof by aptamer/gold nanoparticles-poly(3,4-ethylene dioxythiophene) modified GC electrode
【24h】

Isolation of HL-60 cancer cells from the human serum sample using MnO2-PEI/Ni/Au/aptamer as a novel nanomotor and electrochemical determination of thereof by aptamer/gold nanoparticles-poly(3,4-ethylene dioxythiophene) modified GC electrode

机译:使用MnO2-PEI / Ni / Au / Aptamer作为一种新型纳米运动机将HL-60癌细胞从人血清样品中分离,并通过适体/金纳米颗粒 - 聚(3,4-乙烯二氧噻吩)改性GC电极的电化学测定和电化学测定

获取原文
获取原文并翻译 | 示例
           

摘要

Herein, aptamer-modified self-propelled nanomotors were used for transportation of human promyelocytic leukemia cells (HL-60) from a human serum sample. For this purpose, the fabricated manganese oxide nanosheets-polyethyleneimine decorated with nickel/gold nanoparticles (Mn02-PEI/Ni/Au) as nanomotors were added to a vial containing thiolated aptamer KH1C12 solution as a capture aptamer to attach to the gold nanoparticles on the surface of nanomotors covalently. The aptamer-modified self-propelled nanomotors (aptamer(KH1C12)/nanomotors) were then separated by placing the vial in a magnetic stand. The aptamer-modified self-propelled nanomotors were rinsed three times with water to remove the non-attached aptamers. Then, the resulting aptamer(KH1C12)/nanomotors were applied for the on-the-fly" transporting of HL-60 cancer cell from a human serum sample. To release of the captured HL-60 cancer cells, the complementary nucleotide sequences of KH1C12 aptamer solution (releasing aptamer) that has a with capture aptamer was added to phosphate buffer solution (1 M, pH 7.4) containing HL-60/aptamericnici2/nanomotors. Because of the high affinity of capture aptamer to complementary nucleotide sequences of aptamerxmaz, the HL-60 cancer cells released on the surface of aptamer(KH1C12)/nanomotors into the solution. The second goal of the present work was determining the concentration of HL-60 cancer cell in the human serum samples. The electrochemical impedance spectroscopy technique (EIS) was used for the determination of HL-60 cancer cell. The concentration of separated cancer cell was determined by aptamer/gold nanoparticles-poly(3,4-ethylene dioxythiophene) modified GC electrode (Gc/pEDOT-Au-nano/aptamer(KH1C12)). The proposed aptasensor exhibited a good response to the concentration of HL-60 cancer cells in the range of 2.5 x 10(1) to 5 x 10(5) cells mL(-1) with a low limit of detection of 250 cells mL(-1).
机译:在此,适体改性的自推进纳米运动员用于从人血清样品中运输人临时细胞白血病细胞(HL-60)。为此目的,用镍/金纳米颗粒(MN02-PEI / Ni / Au)装饰的制造的氧化锰纳米片 - 聚乙烯亚胺作为纳米热体加入到含有硫醇硫醇化适体KH1C12溶液中,作为捕获适体,以连接到金纳米粒子上共价纳米热管的表面。然后通过将小瓶放置在磁台中来分离适体改性的自行式纳米热量(适体(KH1C12)/纳米热量)。将Aptamer改性的自推进纳米热量用水冲洗三次以除去非附着的适体。然后,将得到的适体(KH1C12)/纳米运动员从人血清样品中施用于随机“转运HL-60癌细胞。释放捕获的HL-60癌细胞,KH1C12的互补核苷酸序列将具有捕获适体的A适体溶液(释放适体)加入含有HL-60 / Aptamericnicnic2 /纳米热量的磷酸盐缓冲溶液(1M,pH7.4)中。由于捕获适体的高亲和力与Aptamerxmaz的互补核苷酸序列, HL-60癌细胞释放在适体(KH1C12)/纳米热量的溶液表面上。本作本作的第二个目的是在人血清样品中确定HL-60癌细胞的浓度。电化学阻抗谱技术(EIS用于测定HL-60癌细胞。通过适体/金纳米颗粒 - 聚(3,4-乙烯二氧噻吩)改性GC电极(GC / PEDOT-AU-NANO / APTAME测定分离的癌细胞浓度R(KH1C12))。提出的Aptasensor对2.5×10(1)至5×10(5)个细胞m1(-1)的范围内的HL-60癌细胞浓度的良好反应,具有250个细胞m1的低限制( -1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号